» Articles » PMID: 36813426

Pathologic Characteristics of Digestive Tract and Liver in Patients with Coronavirus Disease 2019

Overview
Specialty Gastroenterology
Date 2023 Feb 22
PMID 36813426
Authors
Affiliations
Soon will be listed here.
Abstract

With the high prevalence of coronavirus disease-2019 (COVID-19), there has been increasing understanding of the pathologic changes associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This review summarizes the pathologic changes in the digestive system and liver associated with COVID-19, including the injuries induced by SARS-CoV2 infection of GI epithelial cells and the systemic immune responses. The common digestive manifestations associated with COVID-19 include anorexia, nausea, vomiting, and diarrhea; the clearance of the viruses in COVID-19 patients with digestive symptoms is usually delayed. COVID-19-associated gastrointestinal histopathology is characterized by mucosal damage and lymphocytic infiltration. The most common hepatic changes are steatosis, mild lobular and portal inflammation, congestion/sinusoidal dilatation, lobular necrosis, and cholestasis.

Citing Articles

Evaluating male sexual function and reproductive health during Omicron outbreak in China.

Xiao J, Liu B, Matsika J, Wu R, Tang Z, Xu H PLoS One. 2024; 19(11):e0310145.

PMID: 39509398 PMC: 11542781. DOI: 10.1371/journal.pone.0310145.


Efficacy and safety of aniseed powder for treating gastrointestinal symptoms of COVID-19: a randomized, placebo-controlled trial.

Mosaffa-Jahromi M, Molavi Vardanjani H, Fuzimoto A, Hunter J, Bagheri Lankarani K, Pasalar M Front Pharmacol. 2024; 15:1331177.

PMID: 38292939 PMC: 10824915. DOI: 10.3389/fphar.2024.1331177.

References
1.
Ramos-Rincon J, Alenda C, Garcia-Sevila R, Silva-Ortega S, Garcia-Navarro M, Vidal I . Histopathological and virological features of lung, heart and liver percutaneous tissue core biopsy in patients with COVID-19: A clinicopathological case series. Malays J Pathol. 2022; 44(1):83-92. View

2.
Zhao C, Rapkiewicz A, Maghsoodi-Deerwester M, Gupta M, Cao W, Palaia T . Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19). Hum Pathol. 2020; 109:59-68. PMC: 7722493. DOI: 10.1016/j.humpath.2020.11.015. View

3.
Mohamed D, El-Sayed Ghoneim M, Abu-Risha S, Abdelsalam R, Farag M . Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol. 2021; 27(28):4504-4535. PMC: 8326263. DOI: 10.3748/wjg.v27.i28.4504. View

4.
Vanella G, Capurso G, Burti C, Fanti L, Ricciardiello L, Souza Lino A . Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol. 2021; 8(1). PMC: 7907837. DOI: 10.1136/bmjgast-2020-000578. View

5.
Daneshgaran G, Dubin D, Gould D . Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol. 2020; 21(5):627-639. PMC: 7456663. DOI: 10.1007/s40257-020-00558-4. View